| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci A Franke, DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, ... Nature genetics 42 (12), 1118-1125, 2010 | 3129 | 2010 |
| Ischemia/reperfusion injury and cardioprotective mechanisms: role of mitochondria and reactive oxygen species MG Perrelli, P Pagliaro, C Penna World journal of cardiology 3 (6), 186, 2011 | 2725* | 2011 |
| Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019 | 835 | 2019 |
| Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut A Michielan, R D’Incà Mediators of inflammation 2015, 2015 | 686 | 2015 |
| East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort J Burisch, N Pedersen, S Čuković-Čavka, M Brinar, I Kaimakliotis, ... Gut 63 (4), 588-597, 2014 | 563 | 2014 |
| Non-invasive diagnosis of advanced fibrosis and cirrhosis S Sharma, K Khalili, GC Nguyen World journal of gastroenterology: WJG 20 (45), 16820, 2014 | 460* | 2014 |
| European evidence-based consensus: inflammatory bowel disease and malignancies V Annese, L Beaugerie, L Egan, L Biancone, C Bolling, C Brandts, ... Journal of Crohn's and Colitis 9 (11), 945-965, 2015 | 449 | 2015 |
| Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ... Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011 | 373 | 2011 |
| High-density mapping of the MHC identifies a shared role for HLA-DRB1* 01: 03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis P Goyette, G Boucher, D Mallon, E Ellinghaus, L Jostins, H Huang, ... Nature genetics 47 (2), 172-179, 2015 | 329 | 2015 |
| Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease R D’Incà, E Dal Pont, V Di Leo, A Ferronato, W Fries, MG Vettorato, ... International journal of colorectal disease 22, 429-437, 2007 | 294 | 2007 |
| Can calprotectin predict relapse risk in inflammatory bowel disease? R D'incà, E Dal Pont, V Di Leo, L Benazzato, M Martinato, F Lamboglia, ... Official journal of the American College of Gastroenterology| ACG 103 (8 …, 2008 | 282 | 2008 |
| Topical butyrate improves efficacy of 5‐ASA in refractory distal ulcerative colitis: results of a multicentre trial P Vernia, V Annese, G Bresci, G d’Albasio, R d’Incà, S Giaccari, ... European journal of clinical investigation 33 (3), 244-248, 2003 | 266 | 2003 |
| Intestinal permeability test as a predictor of clinical course in Crohn’s disease R D’Incà, V Di Leo, G Corrao, D Martines, A D’Odorico, C Mestriner, ... The American journal of gastroenterology 94 (10), 2956-2960, 1999 | 259 | 1999 |
| Zinc supplementation tightens “leaky gut” in Crohn’s disease GC Sturniolo, V Di Leo, A Ferronato, A D’Odorico, R D’Incà Inflammatory Bowel Diseases 7 (2), 94-98, 2001 | 253 | 2001 |
| Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth L Gatta, C Scarpignato, RW McCallum, L Lombardo, M Pimentel, R D'Incà, ... Alimentary pharmacology & therapeutics 45 (5), 604-616, 2017 | 243 | 2017 |
| Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study J Burisch, G Kiudelis, L Kupcinskas, HAL Kievit, KW Andersen, ... Gut 68 (3), 423-433, 2019 | 234 | 2019 |
| Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ... Nature communications 7 (1), 13507, 2016 | 222 | 2016 |
| IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes Y Momozawa, J Dmitrieva, E Théâtre, V Deffontaine, S Rahmouni, ... Nature communications 9 (1), 2427, 2018 | 212 | 2018 |
| Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter study G Meucci, R Fasoli, S Saibeni, D Valpiani, R Gullotta, E Colombo, ... Inflammatory bowel diseases 18 (6), 1006-1010, 2012 | 188* | 2012 |
| Diagnosis and management of Wilson's disease: results of a single center experience V Medici, CP Trevisan, R D'Incà, M Barollo, L Zancan, S Fagiuoli, ... Journal of clinical gastroenterology 40 (10), 936-941, 2006 | 182 | 2006 |
